Search

everythinglearnresearchcommunity

for

Search:↓

Fixing DNA errors is crucial to prevent skin cancer.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Topical minoxidil showed promise for early male pattern baldness.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Apremilast did not work for treating severe alopecia areata.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.